HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...
Hologic, Inc.’s HOLX GYN Surgical business is likely to have witnessed strong performance — owing to MyoSure and NovaSure — and increasing contributions from the company’s laparoscopic portfolio of ...
Hologic, Inc. HOLX GYN Surgical is expected to have registered vital contributions from MyoSure and the Related fluid system, with an increasing contribution from its laparoscopic portfolio. Moreover, ...
Zacks Investment Research on MSN
Hologic Q1 earnings preview: How should you play the stock now?
Hologic HOLX is set to release first-quarter fiscal 2026 results on Jan. 29, after the closing bell. The Zacks Consensus ...
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...
Zacks Investment Research on MSN
HOLX vs. SYK: Which medical device leader is a solid bet now?
The global medical device industry is characterized by rapid technological advances, innovations and scientific discoveries.
The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine fibroids and cervical cancer, continued innovation in minimally invasive ...
Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results